Tidlira - Tirzepatide 30mg 3ml Pen

Description

Tirzepatide, also known by its development code Mounjaro, is a novel medication designed to address the complex challenges of Type 2 Diabetes Mellitus (T2DM) and weight management. Developed by Eli Lilly, Tirzepatide works as a dual GIP and GLP-1 receptor agonist, helping to regulate blood sugar levels, improve insulin sensitivity, slow gastric emptying, and reduce appetite. This advanced mechanism may support improved glycaemic control, enhanced metabolic function, and significant weight loss when used alongside a healthy diet and lifestyle.

Storage: Keep refrigerated at 2°C – 8°C at all times. Product may differ from picture. Use only as directed by a healthcare professional.